GLP-1 in normal-weight PCOS Two studies investigated the GLP-1 secretion in normal-weight women with PCOS compared with age- and BMI-matched healthy women [45, 46]
Constipation may allow the medication to sit in the body longer and be absorbed more, [while] vomiting and diarrhea may rid the body of the medication [more] quickly before it has time to reach its maximal effect. Finally, although your body weight wont affect the metabolism of Wegovy, your overall body mass index (BMI) and muscle tissue can play a part
If youre already taking a GLP-1 medication like Ozempic, prebiotics can give an extra boost to support appetite control and may even enhance the effects of the drugs
1 The oral formulation, recently launched as a highly anticipated weight-loss treatment, will be available in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths, while the injectable Wegovy will be offered in doses ranging from 0.25 mg to 2.4 mg
Once these meds are on board, they cozy up to the receptors spread out in spots like the pancreas and our noggin